Autoantibodies combined with systemic inflammation markers for predicting bone metastases in non-small cell lung cancer patients.
Saved in:
| Title: | Autoantibodies combined with systemic inflammation markers for predicting bone metastases in non-small cell lung cancer patients. |
|---|---|
| Authors: | Cheng S; Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University, Sichuan, China., Chen D; Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University, Sichuan, China., Du R; Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University, Sichuan, China., Wang C; Department of Thoracic Surgery, the Affiliated Hospital of Southwest Medical University, Sichuan, China., Xian J; Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University, Sichuan, China., Liu L; Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University, Sichuan, China., Wan H; Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University, Sichuan, China., Ye T; Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University, Sichuan, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 26; Vol. 17, pp. 1747604. Date of Electronic Publication: 2026 May 26 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
